These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29689367)

  • 41. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability.
    Pantub K; Wongtrakul P; Janwitayanuchit W
    J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic Studies.
    Hammad RW; Sanad RAB; Abdelmalk NS; Aziz RL; Torad FA
    AAPS PharmSciTech; 2018 Nov; 19(8):3791-3808. PubMed ID: 30280358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
    Zhang T; Chen J; Zhang Y; Shen Q; Pan W
    Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
    Yin J; Hou Y; Yin Y; Song X
    Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation.
    Khurana RK; Bansal AK; Beg S; Burrow AJ; Katare OP; Singh KK; Singh B
    Int J Pharm; 2017 Feb; 518(1-2):289-306. PubMed ID: 28025072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
    Zewail M; Nafee N; Helmy MW; Boraie N
    Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J; Rezazadeh M; Sadeghi H; Khadivar K
    Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties.
    Duong VA; Nguyen TT; Maeng HJ; Chi SC
    Pharm Res; 2019 Jul; 36(10):138. PubMed ID: 31350675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
    Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
    Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers.
    Li X; Wang D; Zhang J; Pan W
    J Pharm Pharmacol; 2009 Nov; 61(11):1485-92. PubMed ID: 19903373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis.
    Khan AS; Ud Din F; Ali Z; Bibi M; Zahid F; Zeb A; Mujeeb-Ur-Rehman ; Khan GM
    Int J Pharm; 2021 Jan; 593():120109. PubMed ID: 33253802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.
    Jiang H; Pei L; Liu N; Li J; Li Z; Zhang S
    Drug Deliv; 2016 May; 23(4):1379-82. PubMed ID: 26162024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine.
    Guo T; Cheng N; Zhao J; Hou X; Zhang Y; Feng N
    Int J Pharm; 2019 Dec; 572():118741. PubMed ID: 31705974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
    Ferreira M; Chaves LL; Lima SA; Reis S
    Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration.
    Zhao C; Liu Y; Fan T; Zhou D; Yang Y; Jin Y; Zhang Z; Huang Y
    Pharm Dev Technol; 2012; 17(4):443-56. PubMed ID: 21222507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Layer-by-Layer Assembled Nanostructured Lipid Carriers for CD-44 Receptor-Based Targeting in HIV-Infected Macrophages for Efficient HIV-1 Inhibition.
    Mahajan K; Rojekar S; Desai D; Kulkarni S; Bapat G; Zinjarde S; Vavia P
    AAPS PharmSciTech; 2021 Jun; 22(5):171. PubMed ID: 34100170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.